ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,012 Cr | ₹1,213 Cr | ₹893 Cr | ₹948 Cr | ₹727 Cr |
What is the latest Cash Flow from Operating Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,012 Cr |
| Mar2024 | ₹1,213 Cr |
| Mar2023 | ₹893 Cr |
| Mar2022 | ₹948 Cr |
| Mar2021 | ₹727 Cr |
How is Cash Flow from Operating Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,012 Cr | -16.57 | |
| Mar2024 | ₹1,213 Cr | 35.75 | |
| Mar2023 | ₹893 Cr | -5.73 | |
| Mar2022 | ₹948 Cr | 30.40 | |
| Mar2021 | ₹727 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,703.6 Cr | -0.5% | -0.8% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.5% |
-0.8% |
-13.4% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses